2 Canadian marijuana stocks to keep a close eye on

Marijuana stocks in Canada continue to tumble as fierce competition prevents the big brands on U.S exchanges from capturing a larger share of the Canadian market. So, which Canadian marijuana stocks should investors keep a close eye on?

Tilray stock

Tilray Brands, Inc. (NASDAQ:TLRY) stock increased by roughly 14% following its most recent quarterly report. However, it later relinquished those gains. 

Are you looking for fast-news, hot-tips and market analysis?

Sign-up for the Invezz newsletter, today.

From the quarterly report, the company broke even on a per-share basis, although sales fell short of forecasts and estimates from various analysts. In addition, following a drop in the business’s stock price, the company recognized a change in the value of convertible debt and warrants, which boosted non-operating income.

Last year, Tilray and Aphria merged. The company also owns a hemp granola manufacturer, a craft brewer, and a distiller, with the intention of selling THC cannabis products through at least some of those businesses whenever federal legalization is achieved in the United States. It also has an agreement in place to give it a stake in MedMen, a troubled cannabis retailer.

Although some marijuana stock analysts have questioned Tilray’s strategy and mode of operation. The stock has a 19-point Composite Rating and a 48-point Earnings per share (EPS) Rating.

Canopy Growth stock

Canopy Growth Corporation (NYSE:CGC) most recent quarterly earnings disappointed investors, continuing the company’s record of disappointing financials. Canopy has pushed back its profit projections, blaming more potent strains in Canada and a delayed distribution rollout in the United States. The company’s executive staff has also been reshuffled.

Canopy operates a CBD business in the United States, with brands like Martha Stewart’s. It has agreements in place to buy Acreage Holdings, a cannabis operator in the United States, and Wana Brands, an edibles manufacturer in the United States, in the near future.

Amongst many marijuana stock analysts, the stock of Canopy Growth has a Composite Rating of 24 and Earnings per share (EPS) Rating of 56. This is quite a good rating.

Where to buy right now

To invest simply and easily, users need a low-fee broker with a track record of reliability. The following brokers are highly rated, recognised worldwide, and safe to use:

1. Etoro, trusted by over 13m users worldwide. Register here >
2. bitFlyer, simple, easy to use and regulated. Register here >